Block of hERG Channels by Berberine: Mechanisms of Voltage- and State-Dependence Probed With Site-Directed Mutant Channels

Berberine prolongs the duration of cardiac action potentials without affecting resting membrane potential or action potential amplitude. Controversy exists regarding whether berberine exerts this action by preferential block of different components of the delayed rectifying potassium current, IKr and IKs. Here we have studied the effects of berberine on hERG (IKr) and KCNQ1/KCNE1 (IKs) channels expressed in HEK-293 cells and Xenopus oocytes. In HEK-293 cells, the IC50 for berberine was 3.1 ± 0.5 μM on hERG compared with 11 ± 4% decreases on KCNQ1/KCNE1 channels by 100 μM berberine. Likewise in oocytes, hERG channels were more sensitive to block by berberine (IC50 = 80 ± 5 μM) compared with KCNQ1/KCNE1 channels (∼20% block at 300 μM). hERG block was markedly increased by membrane depolarization. Mutation to Ala of Y652 or F656 located on the S6 domain, or V625 located at the base of the pore helix of hERG decreased sensitivity to block by berberine. An inactivation-deficient mutant hERG channel (G628C/S631C) was also blocked by berberine. Together these findings indicate that berberine preferentially blocks the open state of hERG channels by interacting with specific residues that were previously reported to be important for binding of more potent antagonists.

[1]  Jules C Hancox,et al.  High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656. , 2004, Biochemical and biophysical research communications.

[2]  Gregory W. Kauffman,et al.  Physicochemical Features of the hERG Channel Drug Binding Site* , 2004, Journal of Biological Chemistry.

[3]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[4]  J. Hancox,et al.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652 , 2003, British journal of pharmacology.

[5]  Michael C Sanguinetti,et al.  Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain. , 2003, Molecular pharmacology.

[6]  Jules C Hancox,et al.  Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. , 2002, Journal of pharmacological and toxicological methods.

[7]  Michael C Sanguinetti,et al.  Molecular Determinants of Voltage-dependent Human Ether-a-Go-Go Related Gene (HERG) K+ Channel Block* , 2002, The Journal of Biological Chemistry.

[8]  Yu Huang,et al.  Cardiovascular actions of berberine. , 2006, Cardiovascular drug reviews.

[9]  A. Brown,et al.  Molecular determinants of inactivation and dofetilide block in ether a-go-go (EAG) channels and EAG-related K(+) channels. , 2001, Molecular pharmacology.

[10]  I Kodama,et al.  Open channel block of HERG K(+) channels by vesnarinone. , 2001, Molecular pharmacology.

[11]  H. Witchel,et al.  Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide. , 2001, Biochemical and biophysical research communications.

[12]  J. Balser,et al.  Probing the Interaction Between Inactivation Gating and d-Sotalol Block of HERG , 2000, Circulation research.

[13]  Jun Chen,et al.  A structural basis for drug-induced long QT syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Duff,et al.  Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites. , 2000, Molecular pharmacology.

[15]  M. Sanguinetti,et al.  Mutations of the S4‐S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes , 1999, The Journal of physiology.

[16]  A. Brown,et al.  Molecular determinants of dofetilide block of HERG K+ channels. , 1998, Circulation research.

[17]  Y. X. Wang,et al.  Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine. , 1997, Journal of cardiovascular pharmacology.

[18]  M. Sanguinetti,et al.  Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.

[19]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[20]  J. Sánchez-Chapula,et al.  Increase in action potential duration and inhibition of the delayed rectifier outward current IK by berberine in cat ventricular myocytes , 1996, British journal of pharmacology.

[21]  Gary Yellen,et al.  The inward rectification mechanism of the HERG cardiac potassium channel , 1996, Nature.

[22]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[23]  F. Riccioppo Neto Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit. , 1993, British journal of pharmacology.

[24]  W. Stühmer,et al.  Electrophysiological recording from Xenopus oocytes. , 1992, Methods in enzymology.

[25]  R. Horn,et al.  Muscarinic activation of ionic currents measured by a new whole-cell recording method , 1988, The Journal of general physiology.

[26]  C. Armstrong Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons , 1971, The Journal of general physiology.